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Abstract: Soluble oligomers are potent toxins in many neurodegenerative diseases, but little is known
about the structure of soluble oligomers and their structure-toxicity relationship. Here we prepared on-
pathway oligomers of the 140-residue protein R-synuclein, a key player in Parkinson’s disease, at
concentrations an order of magnitude higher than previously possible. The oligomers form ion channels
with well-defined conductance states in a variety of membranes, and their -structure differs from that of
amyloid fibrils of R-synuclein.
Introduction
In many neurodegenerative diseases, such as Alzheimer’s and
Parkinson’s disease, proteinaceous aggregates are observed in
damaged neuronal regions.1 The relationship of neuronal
inclusions to disease has been intensively studied and provided
strong support for the importance of protein aggregation for
neurodegeneration.1,2 Accumulating evidence, however, suggests
that it is not the insoluble aggregates identified by light
microscopy but rather soluble oligomers that are the most
neurotoxic species.2 Despite their importance for neurodegen-
eration and for development of therapeutic treatments, little is
known about the structure of soluble oligomers and their
structure-toxicity relationship.3 This is due to the nature of
soluble oligomers; they are intermediates of the aggregation
process, and are therefore an extremely transient and labile
species.3 As soon as their concentration reaches a few percent,
the so-called on-pathway oligomers are rapidly converted into
amyloid fibrils, insoluble aggregates with an archetypical
-structure. In contrast, addition of small compounds, metals,
lipids, and molecular chaperones to either monomeric or fibrillar
protein can lead to formation of aggregation intermediates that
are often stable and characterized as unordered.4-8 Soluble
oligomers of the amyloid- peptide that were stabilized by
addition of fatty acids were shown to have a -sheet secondary
structure.9 In many cases, additive-stabilized oligomers do not
seed aggregation of the wild-type protein and are therefore called
off-pathway. Off-pathway aggregates are believed to be non-
toxic. The difficulty to produce oligomeric intermediates of
defined properties in sufficient quantities has hampered efforts
to (1) elucidate their structural properties, (2) develop molecular
tools to monitor their formation, and (3) establish the structural
basis of their toxicity.
In Parkinson’s disease, aggregation of the 140 amino acid
protein R-synuclein (RS) is believed to be a key factor.10,11 In
aqueous solution, monomeric RS is highly flexible and belongs
to the class of intrinsically disordered proteins,12 with transient
long-range interactions stabilizing a closed conformation.13,14
Upon binding to negatively charged membranes, the N-terminal
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domain assumes an R-helical structure.15,16 During aggregation
RS undergoes major conformational changes populating different
oligomeric states and finally converts into a cross- structure,
which is characteristic of amyloid fibrils.2 Solid-state nuclear
magnetic resonance (NMR) spectroscopy, electron paramagnetic
resonance, and quenched hydrogen/deuterium exchange revealed
that the fibrillar core of amyloid fibrils of RS comprises five
-strands within residues 35-96.17-19 In addition, a model for
the fold of RS fibrils was proposed.19 CD and Fourier transform
infrared spectroscopy of RS oligomers stabilized by the ag-
gregation inhibitor baicalin indicated the presence of -sheet
structure.20,21 In addition, fluorescence resonance energy transfer
measurements pointed to conformational differences between
early-stage and late-stage oligomers of RS.22 Detailed structural
information for soluble oligomers of RS, in particular for those
that are on-pathway to amyloid fibrils and are believed to be
the most toxic species in Parkinson’s disease,10 is missing.
Here we prepared on-pathway oligomers of RS at micromolar
concentrations and characterized their structural and functional
properties by a combination of thioflavin T (ThT) fluorescence,
electron microscopy, atomic force microscopy, electrophysi-
ological measurements, and solid-state NMR spectroscopy. The
preparation method was based on our recent finding that amyloid
fibrils of RS are sensitive to low temperatures and dissociate
into smaller aggregates and monomers in supercooled solution.23
We demonstrate that this allows preparation of on-pathway
oligomers at concentrations an order of magnitude higher than
previously possible, that the RS oligomers form ion channels
with well-defined conductance states in a variety of membranes,
and that the -structure of the oligomers is nonfibrillar.
Experimental Section
Sample Preparation for Fibrillization and Dissociation of
rS Fibrils. Recombinant RS was expressed and purified as
described.14 15N- and 13C/15N-labeled RS amyloid fibrils were
prepared by incubating 100 µM freshly prepared 15N- and 13C/15N-
labeled RS in a solution of 50 mM Hepes and 100 mM NaCl at
pH 7.4 in the presence of 0.01% sodium azide in glass vials.
Incubation was carried out under continuous stirring with a
microsized stir bar at 37 °C until a steady state was reached
according to ThT fluorescence.24 Matured fibrils were collected by
centrifugation at 60000 rpm (∼215000g) with a TLA 100.3
ultracentrifuge (Beckman Coulter). The collected fibrils were
dissolved into distilled water and centrifuged twice to remove
residual monomeric protein. For experiments in supercooled water
at -15 °C, monomeric RS (0.1 mM protein concentration) and
fibrillar RS were suspended in 50 mM sodium phosphate buffer
(pH 7.4) and 300 mM NaCl and injected into glass capillaries of
0.8 mm inner diameter.23
Supercooling of rS Fibrils. The cooling device (Figure S1,
Supporting Information) uses an RKS cryostat with an RK20
thermostat (Lauda, Ko¨nigshofen, Germany). The cooling liquid,
poly(dimethylsiloxane), is directed into silicon tubes by an adjust-
able external pump. The tubes are connected with a jacketed cooling
glass vessel with joints (Figure S1b, c), which is itself filled up
with the cooling liquid. The circuit is closed by another tube leading
back to the cryostat. Within the cooling vessel were placed a
thermometer (to measure the temperature of the cooling liquid
directly inside the vessel) and the sample, fixed by a silicon plug
with two holes. Up to 100 capillaries can be placed inside the vessel.
The tubes are insulated by foamed plastic. A Styrofoam box, whose
holes are covered by aluminum foil, insulates the cooling vessel.
Preparation of Oligomers for Solid-State NMR
Measurements. To collect a sufficient amount of RS oligomers
for solid-state NMR spectroscopy, 10 mg of 13C/15N-labeled
monomeric RS was aggregated into amyloid fibrils and incubated
at -13 °C in the cryostat platform. After cold-induced dissociation
the solution contains a mixture of monomers, oligomers, and
residual fibrils/protofibrils. We removed residual fibrils/protofibrils
from the solution by centrifugation in a table-top centrifuge at 5000
rpm for 15 min. The upper 50 vol % of the supernatant was
collected, and the lower 50 vol % was discarded. The collected
upper portion was further centrifuged for 3 h at 65000 rpm
(∼230000g), and the lower 50% portion was collected. This step
was repeated several times to reduce the sample volume to 100
µL. After the last centrifugation, the upper and lower 50% portions
of the solution were separated and immediately freeze-trapped in
liquid nitrogen. For both samples, solid-state NMR spectra were
measured. 1D 13C cross-polarization spectra for the two samples
were highly similar. Only the spectrum that was obtained for the
upper 50% of the solution obtained from the last step of centrifuga-
tion is shown in Figure 7a.
Preparation of Oligomers for the Seeding Experiment.
Oligomer seeds were prepared as described above except for a
different starting amount of RS (100 µM in 300 µL). Neglecting
any loss of oligomers during the purification procedure and
considering the initial sample condition, the concentration of
oligomers can have a maximum value of ∼500 µM (in terms of
monomeric RS) in 30 µL, taking into account a conversion
efficiency of about 50%. The purified oligomer solution (13 µL)
was added to 500 µL of a freshly prepared solution of monomeric
RS (monomer concentration of 100 µM). Thus, the total amount
of RS in terms of monomer concentration was at most ∼110 µM
in 513 µL.
Atomic Force Microscopy (AFM). AFM images were recorded
using an Asylum MFP-3D machine (Asylum Research, California).
A 5-10 µL volume of the sample solution was deposited on glass
or a freshly prepared mica surface. Impurities on the glass surface
were removed by plasma treatment before sample deposition. After
drying in air for 1-2 h, unbound sample and buffer were washed
away with 100 µL of distilled water.
Transmission Electron Microscopy. RS oligomers were pre-
pared on a glow-discharged carbon foil and stained with 1% uranyl
acetate. The samples were evaluated with a CM 120 transmission
electron microscope (FEI, The Netherlands). Images were taken
with a 2048 I 2048 TemCam 224 A camera (TVIPS, Germany) in
spot mode at 195000-fold magnification at a -1.15 µm defocus.
Polyacrylamide Gel Electrophoresis (PAGE). Conventional
sodium dodecyl sulfate (SDS)-PAGE was performed with a sample
buffer containing 10% SDS. For native gel electrophoresis, 4-15%
precast polyacrylamide gels (Bio-Rad Laboratories, California) were
used.
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Dynamic Light Scattering (DLS). DLS was performed with a
Wyatt DynaPro Titan (Wyatt Technology, California) equipped with
a temperature controller. A 12 µL volume of purified oligomers at
a concentration of ∼100 µM (in terms of RS monomers) was used.
Samples were filtered with a 0.2 µm syringe filter before the
measurement. Hydrodynamic radius values were calculated from
the acquired translational diffusion coefficient using software that
comes with the DynaPro instrument.
Thioflavin T Fluorescence. Aliquots of 10 µL of each sample
were taken from the assay and diluted into 2 mL of 50 µM ThT in
50 mM glycine buffer, pH 8.0. ThT fluorescence spectra were
measured using a Varian Cary Eclipse fluorescence spectropho-
tometer (Varian Inc., California) at an excitation wavelength of 446
nm and an emission wavelength range of 460-600 nm. Fluores-
cence at 480 nm was used for determination of the relative content
of RS fibrils in the sample.25
Solution-State NMR Spectroscopy. Solution-state NMR spectra
were recorded on Bruker Avance 600 and 700 MHz NMR
spectrometers equipped with a z-axis gradient TXI probe (Bruker
Biospin, Germany). Aggregation and dissociation of amyloid fibrils
was followed by recording a series of 1D 1H and 2D 1H-15N HSQC
spectra. For aggregation, standard 5 mm NMR tubes were used.
For supercooling, 10 capillaries (i.d. 0.8 mm) were placed into a 5
mm NMR tube.
Quantification of rS Oligomers. Since no direct method exists
for quantification of oligomers, an indirect method was introduced.
Supposing that RS has three aggregation statessmonomer, oligo-
mer, and fibrilsthe amount of RS oligomers can be estimated from
the total amount of RS by determining the relative concentrations
of monomeric and fibrillar protein. The concentration of monomers
present in the sample at different stages of aggregation and cold-
induced dissociation was determined on the basis of the signal
intensity in 2D 1H-15N HSQC spectra. The relative concentration
of fibrils, on the other hand, was estimated from the ThT
fluorescence intensity. The amount of protein not accounted for by
either monomers or fibrils was assigned as oligomeric protein.
Solid-State NMR Spectroscopy. Solid-state NMR experiments
were conducted on a 14.1 T NMR spectrometer (corresponding to
a 1H resonance frequency of 600 MHz) equipped with a 4 mm
triple-resonance (1H, 13C, 15N) magic-angle spinning probe (Bruker
Biospin, Germany). All experiments were carried out at a probe
temperature of -25 °C and a magic-angle spinning rate of 8.5 kHz.
Cross-polarization spectra for RS monomers, oligomers, and fibrils
were recorded using high-power proton-decoupling (SPINAL6426
with rf amplitudes of 80-90 kHz).
Immunoblotting (Dot Blotting). RS oligomers and amyloid
fibrils were spotted onto a nitrocellulose membrane (Protran BA85,
0.45 µm pore size). Blotting was performed using the conformation-
specific A11 antibody (1:1000, Invitrogen’s Biosource) as described
previously.27 The amount of protein used for each spot was around
10 µg. In parallel, the samples were blotted using the anti-RS
antibody (1:2000, BD Biosciences).
Ion Channel Measurements in Planar Bilayers. Monomers,
soluble oligomers, and fibrils were prepared as explained above.
The membranes were formed from diphytanoylphosphatidylcholine
(DiphPC) dissolved in n-decane. The aqueous electrolyte solutions
were unbuffered and had a pH of ∼6 unless otherwise indicated
(temperature 20 °C, voltage +100 mV). The average conductance,
G, of the states (Table 1) was calculated from at least 100 single
events observed with RS oligomers in lipid bilayer experiments.
Frequencies of pore formation of monomeric, fibrillar, and oligo-
meric RS were determined in the following way: Three different
measurement rounds were performed distributed over the time
period of one year. Each round of measurement was performed
using freshly prepared RS monomers, fibrils, and oligomers (starting
from freshly prepared recombinant RS) and consisted of 6-14
membrane preparations. Pore formation was counted as successful
when (i) pores were formed at +100 mV or less and (ii) more than
five times per preparation. Subsequently, the number of successful
pore formation events was averaged over all membrane preparations.
(-)-Epigallocatechin gallate (EGCG) was obtained from Sigma-
Aldrich, and a 10 mM stock solution was freshly prepared in the
same buffer for the experiments. For the EGCG-mixed sample, a
specified volume of this EGCG solution was added to the RS sample
and the mixture was incubated at room temperature for a given
time. The same measurement procedure was applied to these
samples.
Results and Discussion
Preparation of Soluble Oligomers of rS at Concentrations
an Order of Magnitude Higher Than Previously Possible.
Previously, cold-induced dissociation of amyloid fibrils was
achieved by injection of a 300 µL solution containing RS fibrils
into 10 glass capillaries, placement of the capillaries into a 5
mm nuclear magnetic resonance (NMR) tube, and incubation
of the NMR tube at -15 °C for one day in the vibration-free
environment of an NMR spectrometer. In the present study, we
replaced the NMR spectrometer by a cryostat connected to a
jacketed cooling vessel (Figure S1, Supporting Information).
The vessel was cooled to -13 °C and accommodated 100
capillaries.
We followed the process of cold-induced dissociation of
amyloid fibrils by transmission electron microscopy (TEM).
Before cold dissociation, typical amyloid fibrils were visible
(Figure 1a). After cold-induced dissociation, only a small
number of fibrils and protofilaments were left and a large amount
of oligomers was present (Figure 1b). Centrifugation for 15 min
at 5000 rpm in a table-top centrifuge and careful pipetting of
the upper 50 vol % of the supernatant resulted in a sample in
which only spherical oligomers were visible (Figure 1c).
According to TEM and AFM, the spherical species were
grouped into two classes with diameters of 15-20 and 20-30
nm, respectively (Figure 1c,d). The dimensions are similar to
those previously observed by TEM and AFM for on-pathway
oligomers.3 Dynamic light scattering of the oligomers in solution
also showed mostly two species with hydrodynamic radii of
∼35 and ∼125 nm (Figure 1e). Note that the hydrodynamic
radius values are only rough estimates assuming a globular shape
and that EM and AFM analysis is potentially influenced by
selective binding to the support. Native PAGE confirmed the
presence of a large amount of soluble oligomers (Figure 1f),
while SDS-PAGE showed that the oligomers are not resistant
to SDS (data not shown).
A quantitative analysis of the concentration of soluble
oligomers obtained by cold-induced dissociation of amyloid
fibrils was performed by a combination of NMR spectroscopy
and fluorescence measurements (Figure 2). Initially, a 1H-15N
two-dimensional heteronuclear correlation (HSQC) spectrum
was recorded on a sample of monomeric 15N-labeled RS. Next,
the sample was aggregated for one week, and the concentration
of remaining monomeric protein was estimated by NMR.
Compared to the spectrum before aggregation, the intensity was
reduced to about 15% (Figure 2a). We then separated the mono-
meric protein from the fibrils by centrifugation and subjected
the RS fibrils to cold-induced dissociation as described previ-
ously.23 After two days of incubation in supercooled water, we
determined the concentration of monomeric protein by an
identical two-dimensional 1H-15N HSQC spectrum; approxi-
(25) LeVine, H. Methods Enzymol. 1999, 309, 274–84.
(26) Fung, B. M.; Khitrin, A. K.; Ermolaev, K. J. Magn. Reson. 2000,
142, 97–101.
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Cotman, C. W.; Glabe, C. G. Science 2003, 300, 486–9.
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Figure 1. Morphology of RS fibrils and soluble oligomers. (a) TEM image of freshly prepared RS fibrils, (b) the fibrils after one day of incubation in
supercooled water at -13 °C, and (c) the supernatant after centrifugation for 15 min at 5000 rpm (∼2300g) in 50 mM sodium phosphate buffer, pH 7.4, 300
mM NaCl. (d) AFM image of RS oligomers. The conditions are identical to those of (c). (e) Hydrodynamic radii of the purified RS oligomers as estimated
by dynamic light scattering. Two oligomeric species were detected with sizes of ∼35 and ∼125 nm, respectively. Monomeric protein was also detected. (f)
Native gradient (4-15%) polyacrylamide gel of RS monomers (lane 1) and RS oligomers (lanes 2-4). Gels were stained with Coomasie blue (lanes 1 and
2) and silver (lane 3). Lane 4 shows the staining of the RS oligomers using the Syn-1 antibody on a Western blot.
Figure 2. Quantification of RS oligomers. (a) Decrease of NMR signal intensities of RS residues in two-dimensional 1H-15N HSQC spectra during aggregation.
To determine the concentration of monomeric protein before aggregation, a two-dimensional 1H-15N HSQC spectrum was recorded on a sample of 15N-
labeled RS in 20 mM Tris, 100 mM NaCl, pH 7.4. Next the sample was incubated for fibrillization. During aggregation the decrease in the concentration
of monomeric RS was monitored by two-dimensional 1H-15N HSQC spectra. After 168 h, the signal intensity was reduced to on average 15% when
compared to the spectrum before aggregation (brown line). No additional decrease in monomer concentration was observed at 175 h of aggregation (dark
blue line), indicating that the saturation point was reached. (b) Concentration of monomeric protein after two days of incubation in supercooled water
estimated from a two-dimensional 1H-15N HSQC spectrum. (c) Comparison of the ThT fluorescence signal before (black) and after (green) one day of
incubation in supercooled water at -13 °C suggests that 20-30% of the fibrillar material remained. The combined data demonstrate that 55-65% of the RS
fibrils were transformed into oligomeric aggregation intermediates that did not stain for the amyloid-specific dye ThT.
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mately 15% of the fibrils dissociated into monomeric proteins
(Figure 2b). In a control measurement, RS fibrils were stored
in capillary tubes at room temperature for two days and showed
no monomeric protein in a two-dimensional HSQC spectrum.
Next, we estimated the concentration of residual RS fibrils by
ThT fluorescence. Comparison of the ThT fluorescence signal
before (black) and after (green) cold-induced dissociation
suggested that 20-30% of the fibrillar material remained (Figure
2c). The combined data demonstrate that 55-65% of the RS
fibrils were transformed into aggregation intermediates that did
not stain for the amyloid-specific dye ThT. Thus, the method
of cold-induced dissociation of amyloid fibrils produces soluble
oligomers at concentrations that are an order of magnitude higher
than those present during aggregation.
Soluble Oligomers of rS Dissociated from Amyloid Fibrils
Are On-Pathway Aggregation Intermediates. Following quan-
tification, we tested whether the soluble RS oligomers are
aggregation intermediates that are able to accelerate aggregation
of monomeric protein. At 37 °C with agitation, monomeric RS
showed the typical sigmoidal increase in ThT fluorescence
characteristic of nucleation-dependent aggregation (Figure 3a).
In contrast, addition of 13 µL of the oligomer solution, which
changed the total amount of RS by less than 15%, dramatically
reduced the lag phase for nucleation, indicating that the RS
oligomers are on-pathway intermediates (Figure 3a). An even
more pronounced acceleration of aggregation was observed
when the sample, which was obtained directly from supercooling
and contained a mixture of monomers, oligomers, and fragments
of fibrils, was again incubated in the aggregation conditions at
37 °C with agitation (Figure 3b). The high capacity of the
purified oligomers to form fibrils and promote aggregation was
further supported by the observation that purified oligomer
solutions, which were stored at 4 °C without agitation in the
cold room, had already formed a large amount of amyloid fibrils
after two days (Figure S2, Supporting Information).
Soluble Oligomers of rS Dissociated from Amyloid Fibrils
Comprise a Neurotoxic Epitope. Little is known about the
structural properties of aggregation intermediates in vivo, and
antibodies are, besides dyes such as thioflavin S that stain
primarily amyloid fibrils, the only available tool to probe
differences in the conformation of aggregation intermediates.
In particular, the antibody A11 has been shown to be useful in
a number of applications as it recognizes a sequence-independent
structural feature common to soluble oligomers associated with
neurotoxicity.27 Here we tested whether the soluble oligomers
obtained by cold dissociation of amyloid fibrils of RS and
purified as described in the Experimental Section, react with
the A11 antibody. Figure 4 shows that A11 stains the RS
oligomers on dot blots, but does not react with monomeric or
fibrillar RS, in agreement with previous reports.5,7 Thus, soluble
oligomers of RS dissociated from amyloid fibrils contain an
epitope that is important for neurotoxicity in vivo.
Soluble rS Oligomers Form Pores with Well-Defined
Conductance States in a Variety of Membranes. Since the
observation of channel activity of amyloidogenic proteins in
1993, it has been considered as a potential mechanism of toxicity
in neurodegenerative diseases.28,29 Soluble oligomers became
a major candidate that may react with membranes to damage
key processes within the cell.30 We studied whether the soluble
RS oligomer, identified as a neurotoxic intermediate, is able to
form pores in planar lipid bilayers made by the Mu¨ller-Rudin
technique.31 Similarly, monomers and fibrils were also studied
in a control experiment. Monomers and fibrils showed only
minor or no channel-forming activity in painted lipid bilayer
(28) Arispe, N.; Rojas, E.; Pollard, H. B. Proc. Natl. Acad. Sci. U.S.A.
1993, 90, 567–71.
(29) Arispe, N.; Pollard, H. B.; Rojas, E. Ann. N.Y. Acad. Sci. 1994, 747,
256–66.
(30) Cookson, M. R.; van der Brug, M. Exp. Neurol. 2008, 209, 5–11.
(31) Benz, R.; Janko, K.; Boos, W.; Lauger, P. Biochim. Biophys. Acta
1978, 511, 305–19.
Figure 3. RS oligomers promote aggregation. (a) ThT fluorescence assay monitoring formation of amyloid fibrils. Aggregation starting from purely monomeric
RS (black) is compared to aggregation of monomeric RS in the presence of soluble RS oligomers (gray). A 13 µL volume of purified oligomers was added
to a 100 µM RS monomer solution prepared in the same buffer (50 mM sodium phosphate, 300 mM NaCl). RS oligomers dramatically accelerated fibril
formation. (b) RS aggregation and reaggregation followed by ThT fluorescence. Experiments were done in 50 mM sodium phosphate buffer, pH 7.4, 300
mM NaCl. In the left panel, aggregation was started from monomeric RS. After ∼70 h, aggregation had reached a saturation point. Subsequently, the sample
was subjected to supercooling. After about two days of incubation at -13 °C, the ThT intensity dropped to about 20% of the original value (middle panel).
At this stage the sample contained a mixture of RS monomers, oligomers, and residual fibrils (Figure 1b). When the sample was warmed to 37 °C with
agitation, a rapid increase in the ThT fluorescence intensity was observed (right panel).
Figure 4. Recognition of RS oligomers by the A11 antibody. RS monomers,
fibrils, and oligomers were deposited on a nitrocellulose membrane and
probed with the oligomer-specific antibody A11 and the RS-specific antibody
Syn1 (BD).
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membranes made from diphytanoylphosphatidylcholine dis-
solved to 1% w/v in n-decane (Figure 5a,b). In contrast, pore
formation was frequently observed for the oligomers, in
particular for membrane voltages of +50 mV and higher (Figure
5b). Not only was this the case with neutral PC membranes
with channel fluctuations at somewhat higher frequency, but
similar conductance states were also observed for PC/PS
mixtures with molar ratios of 4:1, i.e., with 20% negatively
charged lipids probably caused by increased absorption of the
positively charged RS oligomers to the negatively charged
membranes. The typical single-channel recording of Figure 5a
demonstrates that soluble RS oligomers formed many different
conductance states similar to channel-forming peptides such as
melittin.32 This means that the fluctuations started from a small
ground conductance state of about 200 pS and flickered at +100
mV between different higher conductance states that were well-
defined. The major conductance states at a +100 mV trans-
membrane potential were 800 pS and about 1.7 nS in 1 M KCl
solution (Figure 5a and Table 1). An even higher conductance
was observed during bursts, but these states had a very short
lifetime in the millisecond range. The channels formed by the
oligomers are slightly cation-selective according to measure-
ments in different 1 M salt solutions (Table 1). The combined
data show that soluble oligomers obtained by cold-induced
dissociation of amyloid fibrils of the Parkinson disease-
associated protein RS form ion channels with well-defined
conductance states in a variety of membranes in the presence
of a trans-negative potential.
The Green Tea Catechin (-)-Epigallocatechin Gallate
Blocks Oligomer-Induced Pore Formation. The green tea
catechin EGCG was previously shown to reduce RS-induced
neurotoxicity in different cell models.33 The interaction of
EGCG with RS and the structural properties of EGCG-stabilized
oligomers have recently been characterized by E. Wanker and
colleagues.7 In this study it was shown that EGCG binds both
to monomeric and to oligomeric RS, EGCG stimulates assembly
of RS oligomers, the EGCG-stabilized oligomers are SDS
resistant, EGCG binds to the main chain of RS, and EGCG-
induced oligomers are unstructured and are not recognized by
the A11 antibody.
We conducted ion channel measurements with the soluble
RS oligomers and EGCG to investigate whether EGCG redirects
soluble RS oligomers to an oligomeric species that is no longer
able to form pores in planar lipid bilayers. Initially, soluble RS
oligomers, which were obtained by cold-assisted dissociation
of fibrils and were purified as described above, were incubated
with increasing concentrations of EGCG for different incubation
times. Subsequently, the oligomer-EGCG mixture was added
to the cis compartment of the bilayer chamber system, and pore
formation was monitored. When the soluble RS oligomers were
incubated with EGCG at a molar ratio of 1:10 for 2 h, pore
formation was blocked, because only insignificant channel
fluctuations were observed after 2 and 12 h of incubation of
oligomers with EGCG (Figure 6a). A reduction in the amount
of added EGCG showed that a 5-fold excess of EGCG was
enough to impair pore formation (Figure 6b). Thus, a molecular
mechanism of the neuroprotective action of EGCG might be
inhibition of pore formation resulting from soluble RS oligomers.
Solid-State NMR Spectroscopy Indicates That the
-Structure of Soluble rS Oligomers Is Not Fibrillar. Solid-
state NMR spectroscopy is the only method that allows
characterization of the structure of protein aggregates at single-
residue resolution.34 Because of the restricted sensitivity of solid-
state NMR spectroscopy, however, typically as much as 0.5
µmol of isotope-labeled materials (or a 0.5 mM concentration
of the sample) is required. We tested whether the high
(32) Bechinger, B. J. Membr. Biol. 1997, 156, 197–211.
(33) Mandel, S. A.; Amit, T.; Weinreb, O.; Reznichenko, L.; Youdim, M. B.
CNS Neurosci. Ther. 2008, 14, 352–65.
(34) Tycko, R. Q. ReV. Biophys. 2006, 39, 1–55.
Figure 5. RS oligomers obtained by cold-induced dissociation of amyloid
fibrils form pores in planar lipid bilayers. (a) Oligomers but not monomers
or fibrils induced frequent channel formation in planar lipid bilayers formed
from DiphPC/n-decane in 1 M KCl, 1%, at +100 mV. Oligomers were
added to the cis compartment to a final concentration of 2-10 µg/mL. (b)
Frequency of pore formation for monomeric, fibrillar, and oligomeric RS
averaged over three independent sample preparations. Each measurement
consisted of 6-14 membrane preparations. Successful pore formation was
required to fulfill the following criteria: the pore is active (i) at +100 mV
or less and (ii) more than five times per preparation.
Table 1. Different Conductance States Observed with RS
Oligomers in Lipid Bilayer Experiments
salt ground state (pS) state 1 (pS) state 2 (nS) bursts
1 M KCl 300 800 1.7 yes
1 M LiCl 250 900 1.3 yes
1 M KAc (pH 7) 130 750 1.4 yes
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concentration of the soluble oligomers enables solid-state NMR
measurements (Figure 7). For this aim, we prepared amyloid
fibrils of 13C/15N-labeled RS, performed cold-induced dissocia-
tion of the fibrils, removed residual fragments of fibrils and
protofilaments by centrifugation, and concentrated the oligomers
by repeated centrifugation (see the Experimental Section). The
solution remaining in the centrifuge tube contained soluble
oligomers but no protofilaments or fibrils as assessed by TEM
and ThT (data not shown). The consistency of the oligomer
sample during the experiments was confirmed by ThT and TEM
measurements, which were performed after the solid-state NMR
experiments and also showed only soluble oligomers (Figure
7b,c). The combined data suggest that the RS oligomers were
not altered during the solid-state NMR measurements.
Figure 7a compares a 13C cross-polarization solid-state NMR
spectrum of the RS oligomers with spectra observed for
monomeric and fibrillar RS. Monomer and oligomer samples
were measured in the frozen state, whereas fibrillar RS was
measured in the nonfrozen state to exclude the contribution
coming from residual embedded monomeric RS. The NMR lines
observed for fibrillar RS are quite sharp, indicative of a well-
ordered state. In agreement with the conversion of a natively
unfolded monomeric protein into amyloid fibrils with -struc-
ture, an upfield shift of the CR resonances of threonine, valine,
glutamate, and lysine is seen for the RS fibrils (black) when
compared to the monomeric protein (blue).
The spectrum of the soluble oligomers (red) differs from both
the monomeric and the fibrillar spectra. First, the NMR lines
of oligomeric RS are broad, suggesting an intermediate structure.
Second, the C′ and CR resonances of the RS oligomers are
between those of the fibrils and monomers (Figure 7a).
Similar to oligomeric intermediates that are formed during
aggregation into amyloid fibrils, the soluble oligomers obtained
by cold-assisted dissociation of amyloid fibrils are not a single
species. Thus, the red solid-state NMR spectrum shown in
Figure 7a will include contributions from different oligomeric
species. This can include contributions from monomeric protein,
small fractions of oligomers with fibrillar-like -structure, and
oligomers with -structure that differ from amyloid fibrils. At
the same time, however, the NMR spectrum of the soluble
oligomers (Figure 7a) is clearly not just the superposition of
the NMR spectra of the monomer and the fibrils, or the spectrum
of oligomers with fibrillar -structure (as no fibrils were
observed in the sample by EM, AFM, and ThT) (Figures 1 and
7b,c). Moreover, the A11 antibody only recognizes the oligo-
Figure 6. Inhibition of oligomer-induced pores in planar lipid bilayers by EGCG. (a) Dependence on the incubation time for a molar ratio of 1:10 oligomers:
EGCG. (b) Dependence on the EGCG concentration for an incubation time of 2 h. RS oligomers were incubated with EGCG prior to addition to the cis
compartment of the bilayer chamber. Measurements were performed for bilayers formed from DiphPC/n-decane in 1 M KCl, 1%, at +100 mV.
Figure 7. Solid-state NMR spectroscopy of soluble RS oligomers. (a) 13C
cross-polarization solid-state NMR spectra of RS oligomers (red), RS
monomers (blue), and RS fibrils (black). Vertical lines are drawn on selected
resonances observed in RS fibrils. ThT fluorescence spectra (b) and electron
micrographs (c) of the RS oligomer sample directly after the solid-state
NMR experiments. Emission spectra are for the blank (blue), RS fibrils
(black), and soluble RS oligomers (green).
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meric sample but not the monomeric and fibrillar samples
(Figure 4), suggesting that the solid-state NMR spectrum reveals
structural properties of soluble oligomers with a nonfibrillar
structure.
How do these findings compare to structural information
obtained for aggregation intermediates of the amyloid- (A)
peptide and the prion protein? Ishii and colleagues determined
the sequence-specific secondary structures and got some hints
toward the supramolecular structure of an amyloid intermediate
of the 40-residue A peptide using solid-state NMR.35 The
-sheet structure of this late-stage aggregate was fibril-like. In
contrast, liquid-state NMR showed that A oligomers stabilized
by addition of small amounts of aliphatic hydrocarbon chains
of detergents had a mixed parallel and antiparallel -sheet
structure, which is different from that of fibrils.9 Solid-state
NMR studies of oligomers formed by a peptide comprising
residues 106-126 of the human prion protein support formation
of an extended -strand similar to one seen in amyloid fibrils
ofthesamepeptide.36Incontrast,pulse-labelinghydrogen-deuterium
exchange coupled to mass spectrometry indicated that aggrega-
tion of an SH3 domain occurs initially through relatively
disordered species that subsequently evolve to form ordered
aggregates that eventually lead to amyloid fibrils.37 The solid-
state NMR data shown in Figure 7 are in agreement with a
nonfibrillar -structure of soluble oligomers of RS. Moreover,
the observation that the soluble RS oligomers but not the fibrils
formed pores in lipid bilayers points to a lower importance of
-structure for pathological function. In agreement with this
conclusion, a recent study from us showed that RS variants,
for which the -structure was impaired in insoluble late-state
aggregates, caused the most pronounced neurotoxicity in four
different model systems of Parkinson’s disease.38
Conclusion
Accumulating evidence suggests that soluble oligomers are
potent neurotoxins in many neurodegenerative diseases. The
high propensity of the soluble RS oligomers to form pores in
lipid bilayers suggests that reconstitution of RS oligomers into
proteoliposomes might be possible. The reconstituted RS
membrane pore could then be characterized at high resolution
by solid-state NMR and electron paramagnetic resonance
spectroscopy. The ability to prepare soluble oligomers of RS at
high concentrations is essential not only for understanding the
structural basis of oligomer toxicity, but also for the development
of therapeutic treatments and imaging agents for monitoring RS
oligomerization in vivo.
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